Skip to content
  1. 🇮🇪 DHL EXPRESS DELIVERY
  2. 🇮🇪 FREE DELIVERY OVER €50
  3. 🇮🇪 DISPATCHED FROM EUROPE

Minoxidil in Europe: Complete Guide to Hair Loss, 2% vs 5%, Foam, Results & European Brands

Minoxidil is one of the most recognized active ingredients used in topical treatments for androgenetic alopecia, commonly known as male or female pattern hair loss. Yet a consumer searching for minoxidil in Europe quickly discovers that the market is fragmented. The active ingredient may be the same, but the brand name, strength, dosage form, excipients, labeling, approved users and availability can change from one European country to another.

A shopper in the United Kingdom or Ireland may immediately recognize Regaine®. A consumer in Sweden or Finland may know the closely related Rogaine® name. In France, important names include Alopexy®, Minoxidil Bailleul® and Alostil®. Italy has a particularly broad brand landscape that includes Carexidil®, Minoximen®, Minoxidil Biorga®, Trefostil®, Aloxidil®, Minovital®, Phalanx® and Regaine®. Spain has important local names such as Lacovin® and Regaxidil®, while Poland is strongly associated with Loxon®. Sweden currently lists multiple minoxidil families including Minoxidil ABECE, Apofri, NET, Orifarm and Rogaine.

This FOLIGAIN® Europe guide brings those markets together in one place. It explains what minoxidil is, how topical minoxidil is used, the difference between 2% and 5%, foam versus liquid solution, realistic treatment timelines, shedding, side effects, oral versus topical minoxidil, and the most important minoxidil brands encountered around Europe.

Visit the FOLIGAIN® Europe store

The purpose of this guide is not to claim that one brand is universally “best.” A more useful comparison is based on active-ingredient concentration, dosage form, excipients, authorized directions, tolerability, consistency of use, package quantity, local availability and individual suitability. FOLIGAIN® is included throughout as a European minoxidil option available through dedicated FOLIGAIN stores.

Contents

What Is Minoxidil?

Minoxidil is a pharmaceutical active ingredient with a history that extends beyond hair care. Oral minoxidil was developed as a potent antihypertensive drug. Increased hair growth was observed in some patients receiving systemic minoxidil, which helped lead to the development of topical formulations for the scalp.

Today, when consumers search for “minoxidil for hair,” they are usually referring to topical minoxidil supplied as a cutaneous solution, lotion, spray or foam. Two of the most familiar concentrations are 20 mg/ml, equivalent to 2%, and 50 mg/ml, equivalent to 5%. For foams, a 5% presentation is commonly expressed as 50 mg/g.

The distinction between topical and oral minoxidil is essential. Topical products are designed for local application to the scalp. Oral minoxidil produces systemic exposure and has a substantially different medical risk profile. A person should never assume that an oral tablet is simply a more convenient or stronger version of a topical scalp product.

Minoxidil and Androgenetic Alopecia

Androgenetic alopecia is the common patterned form of hair loss associated with genetic susceptibility and androgen signaling. In men it may present as recession at the temples and frontal hairline, thinning across the top of the scalp and progressive loss around the vertex or crown. In women it often appears as reduced density across the upper scalp or widening of the central part.

In androgenetic alopecia, susceptible follicles progressively miniaturize. The hair shafts they produce become shorter, finer and less visible. The process can continue over years, which is why a treatment that supports still-active follicles may have a different effect from treatment started after an area has been completely bald for a long time.

Not every form of hair loss is androgenetic alopecia. Sudden diffuse shedding, patchy loss, postpartum shedding, scalp inflammation, nutritional deficiency, endocrine disease, medication effects and other medical conditions can produce different patterns. Sudden, unexplained, severe or patchy hair loss deserves appropriate medical assessment instead of automatic self-treatment.

How Does Minoxidil Work on Hair?

The exact biological explanation for minoxidil’s hair-growth effect is complex and cannot be reduced to a single simple mechanism. What matters clinically is that topical minoxidil can influence the hair-growth cycle and support follicles that remain capable of producing hair.

Hair cycles through an active growth phase known as anagen, a short transition phase called catagen and a resting/shedding phase known as telogen. In pattern hair loss, susceptible follicles gradually spend less time producing robust terminal hairs and more time producing miniaturized hairs.

Minoxidil is associated with a shift toward active growth in responsive follicles and can increase the diameter and visibility of some miniaturized hairs. It does not create entirely new follicles where follicles no longer exist. This is one reason that realistic expectations and early recognition of patterned thinning matter.

Minoxidil 2% vs Minoxidil 5%

A 2% liquid solution generally contains 20 mg of minoxidil per millilitre. A 5% liquid solution generally contains 50 mg per millilitre. A 5% foam is commonly labeled as 50 mg per gram.

Consumers sometimes assume that a higher percentage is automatically better. That is too simplistic. A higher concentration increases exposure and may also increase the probability of unwanted effects. More importantly, national labeling differs by product, sex, age range and dosage form. For example, a 5% foam may have a different application schedule for women than a 5% product for men in the same country.

FOLIGAIN® offers different minoxidil strengths and formats in selected European markets. The correct choice is the appropriately labeled product for the intended user—not simply the package with the largest percentage printed on it.

Minoxidil Foam vs Liquid Solution

Liquid minoxidil

Liquid solutions are among the most established minoxidil formats in Europe. They may be applied with a dropper, spray pump or other dosing applicator. Liquid can be useful for targeting a defined part of the scalp, especially when the hair is long enough that the user needs to separate the hair and reach the skin.

Some liquid solutions contain propylene glycol and ethanol. These ingredients can help keep minoxidil dissolved and assist delivery, but they can also contribute to dryness, residue, itching or irritation in susceptible people.

Minoxidil foam

Foam offers a different cosmetic experience. It may dry quickly and can be convenient for people who dislike the feel of some liquid vehicles. Some foam formulations avoid propylene glycol. Foam is not automatically stronger or safer, however; the active strength, dose and local directions still matter.

FOLIGAIN® markets different formats in selected European stores, so shoppers can compare more than one application style rather than treating all minoxidil products as interchangeable.

How to Use Topical Minoxidil Correctly

Always follow the directions supplied with the exact product purchased. The following points are general principles, not a substitute for a product leaflet:

  • Apply topical minoxidil to the scalp, not merely to the hair shafts.
  • The scalp is usually expected to be dry before application unless the specific product says otherwise.
  • Use the measured amount and frequency stated on the product.
  • Wash hands after application to reduce accidental transfer to the face or other body areas.
  • Allow the product to dry before applying other products, wearing a hat, lying on a pillow or allowing another person to touch the treated area.
  • Do not apply extra product to “make up” for a missed dose unless the product instructions specifically say to do so.
  • Using more than the recommended amount does not guarantee faster or better hair growth.

Because minoxidil is generally a long-term treatment, ease of use is important. A theoretically excellent formulation that the user dislikes applying may be harder to use consistently than a format that fits comfortably into a morning or evening routine.

Minoxidil Results: What to Expect at 1, 3, 6 and 12 Months

After 1 month

Visible improvement may be minimal. Hair follicles operate on a slow biological cycle, so one month is usually too early for a meaningful cosmetic judgment.

After 2–3 months

Some users notice changes in shedding or small early hairs. Others see little. A lack of dramatic early change is not the same as proof that treatment will never work.

After 3–6 months

This becomes a more useful period for assessing response. Early regrowth may initially look fine, short or lightly pigmented. The cosmetic effect may be subtle before shaft diameter and overall coverage improve.

After 6–12 months

Consistent users can better judge whether density, coverage, shedding or hair-shaft thickness has changed. Responses vary widely between individuals.

For objective tracking, take photographs before treatment and at regular intervals. Keep lighting, hair length, part, camera distance and angle as consistent as possible. Daily mirror checking is much less reliable.

Can Minoxidil Cause Initial Shedding?

Some users notice an increase in hair shedding after starting topical minoxidil. This is commonly called minoxidil shedding. Current UK product information for 5% Regaine foam explains that temporary increased shedding can occur as hairs shift from the resting telogen phase into the growing anagen phase.

That does not mean every increase in hair loss should automatically be dismissed as normal. Severe, prolonged or unusual shedding—especially if it is patchy, painful, inflamed or associated with other symptoms—should be assessed appropriately.

Minoxidil for the Hairline, Temples and Vertex

Searches such as “minoxidil hairline,” “minoxidil temples,” “minoxidil crown” and “minoxidil vertex” are extremely common. Response can differ by area and by the condition of the follicles.

The vertex or crown is one of the classic areas studied in male pattern hair loss. Frontotemporal recession can be more difficult to assess because the degree of miniaturization, duration of loss and exact product labeling vary. A person with visibly miniaturized hairs may have a different response from someone whose frontal area has been smooth and bald for many years.

Do not extend a product to unapproved body areas or assume that directions for one scalp region automatically apply to another. Follow the labeling of the product used.

What Happens If You Stop Minoxidil?

Minoxidil does not permanently remove the underlying genetic tendency toward androgenetic hair loss. Benefits generally depend on continued treatment. When topical minoxidil is stopped, hair that was maintained or supported by treatment can gradually move back toward the course it would have followed without therapy.

This is why minoxidil is better understood as ongoing management than as a short treatment course that permanently “cures” pattern hair loss. Users who are unwilling to continue treatment over time should consider that practical reality before beginning.

Minoxidil Side Effects, Irritation and Warnings

Topical minoxidil can cause local reactions such as itching, dryness, scaling, redness, irritation and contact dermatitis. In some people the vehicle or excipients may contribute to the problem rather than the active ingredient alone.

Greater systemic absorption is possible if minoxidil is misused, applied to damaged or inflamed skin, or used in excessive quantities. Concerning symptoms such as faintness, chest pain, significant palpitations, unexplained swelling or sudden changes in blood pressure require medical attention.

People with known cardiovascular disease or rhythm disorders should discuss use with an appropriate healthcare professional. Pregnancy and breastfeeding also require particular caution and product-specific guidance.

Always read the leaflet for the exact medicine sold in your country because contraindications, age ranges and authorized users may differ across products.

Oral Minoxidil vs Topical Minoxidil

Interest in low-dose oral minoxidil for hair loss has increased, which has also increased searches for Loniten® and generic minoxidil tablets. Oral minoxidil is not interchangeable with topical scalp treatment.

Oral administration creates systemic exposure and can influence blood pressure, heart rate and fluid balance. Loniten is historically an antihypertensive medicine, and current UK medicine information lists oral minoxidil tablets in several strengths.

Minoxidil and TRIOXIDIL®: What Is the Difference?

TRIOXIDIL® is a proprietary FOLIGAIN® cosmetic complex. It is not another name for minoxidil and should not be described as a generic equivalent.

FOLIGAIN® offers topical minoxidil products, TRIOXIDIL® cosmetic products and selected advanced products that combine minoxidil with TRIOXIDIL®. This allows a broader hair-care routine while preserving the important distinction between a pharmaceutical active ingredient and a proprietary cosmetic technology.

Consumers searching “TRIOXIDIL vs minoxidil” should therefore understand that the question is not which name refers to the same molecule—they are different. The more relevant question is how each product fits into a hair-thinning routine and what claims and directions apply to that particular formula.

European Minoxidil Brand Directory

The European minoxidil market is fragmented. The same active ingredient appears under different brand names, concentrations and dosage forms. Some names are current pharmacy brands, some are regional names, some are older search terms and some are imported products from outside Europe.

The sections below provide a broad European reference, while the country links take you directly to the appropriate FOLIGAIN® store for that market.

Regaine®, Rogaine® and Alostil®

Regaine® is one of the best-known commercial names associated with topical minoxidil in Europe. It is especially important in the United Kingdom, Ireland, Germany, Austria and several other European markets. The name is so familiar that some consumers search for “Regaine” when what they actually mean is “topical minoxidil.” That distinction matters: Regaine is a brand, while minoxidil is the active ingredient.

Current UK medicine information lists several Regaine presentations, including 5% foam and 5% solution for men, a 5% once-daily foam for women and a regular-strength women’s product. The exact directions are not identical across every formulation. This is an important reminder that consumers should follow the leaflet for the product they actually purchase instead of borrowing instructions from another minoxidil brand or another country.

In parts of the Nordic region, the closely related brand spelling Rogaine® is used rather than Regaine®. Sweden’s current FASS listings, for example, include Rogaine 50 mg/g foam and Rogaine Forte 50 mg/ml solution. France also has the Alostil® name in the same broader minoxidil landscape, and French regulatory data place Alostil and Regaine in the generic reference context for certain 5% minoxidil solutions.

For a reader comparing Regaine vs FOLIGAIN®, the useful questions are practical rather than purely brand-based: Is the active concentration 2% or 5%? Is the product a foam or liquid? Does the vehicle contain propylene glycol? How often does the local label instruct the user to apply it? How much product is in the pack? Which product is intended for men or women in that particular market? These comparisons are more meaningful than assuming that a famous brand name automatically makes the product stronger or weaker.

If you are comparing Regaine®, Rogaine® and FOLIGAIN®, focus on formulation, concentration, dosage form, labeling and availability rather than on the brand name alone.

Alopexy®

Consumers often search “Alopexy 5%,” “Alopexy minoxidil,” “Alopexy alternative,” “Alopexy or Regaine,” or “Alopexy vs FOLIGAIN.” The correct comparison starts with strength and labeled indication, then moves to vehicle, pack size, dosing format and tolerance. A 5% concentration means the same nominal concentration of active ingredient regardless of brand, but finished products may differ in excipients and instructions.

Minoxidil Bailleul®

Minoxidil Bailleul® is a major French-market reference and one of the most useful branded terms for anyone building a comprehensive European minoxidil resource. France’s official public medicines database currently lists both a 2% cutaneous solution and a 5% cutaneous solution.

The French 2% listing states that it contains 2 g of minoxidil per 100 ml and is indicated for moderate androgenetic hair loss in adult men or women. The 5% product contains 5 g per 100 ml and its current French indication is for adult men with moderate androgenetic hair loss. The official database also identifies propylene glycol and ethanol as excipients of note in these solutions.

This makes Minoxidil Bailleul a useful educational example. Two products can come from the same brand family but have different target users and strengths. It also illustrates why someone who experiences dryness or irritation may want to compare the entire formulation rather than only the active percentage.

Minoxidil Biorga®

Minoxidil Biorga® is another recognized European minoxidil name, particularly relevant to Belgium, Italy and other markets where Bailleul-associated products are known. It is commonly encountered in 2% and 5% topical formulations.

Where Biorga becomes more interesting is in the finished formulation: packaging, applicator, excipients and the local product leaflet may differ from another 2% or 5% product. This is why users moving from Biorga to FOLIGAIN® or another brand should read the new directions rather than simply copying their previous routine.

Carexidil®

Carexidil® is a well-known minoxidil name in Italy. Italian consumers may encounter Carexidil 2% and 5% products and may compare the brand with other minoxidil options such as FOLIGAIN®.

The key educational point is that Carexidil is a commercial product name and minoxidil is the active ingredient. A shopper comparing Carexidil with FOLIGAIN® should identify the exact Carexidil presentation, concentration and instructions before making any comparison.

Minoximen®

Trefostil®

Trefostil® appears in Italian and wider European discussions of topical minoxidil. Consumers may recognize the name from pharmacies, product leaflets or earlier treatment experience.

Aloxidil®

Aloxidil® is best understood as a branded minoxidil reference rather than a product that is necessarily available in every European country. Current local availability should be checked before purchase.

For an Italian user who arrives through an “Aloxidil alternative” search, FOLIGAIN® can be introduced naturally as part of the current FOLIGAIN Italia minoxidil range, with the reader encouraged to compare strength, format and directions.

Minovital®

Minovital® is another name associated with minoxidil in older or market-specific European references, particularly in Italy. Current availability may vary.

The correct tone is cautious: identify Minovital as a brand associated with minoxidil, note that market status may change, and avoid implying that it is currently sold everywhere. Then answer the user’s likely underlying intent—what concentration they need, what topical minoxidil does, how long it takes and what alternatives exist.

Phalanx®

Phalanx should be positioned as a branded minoxidil reference whose exact current market status, strength and package should be checked locally. Readers comparing it with FOLIGAIN® should focus on the current product in front of them rather than on historical descriptions.

Lacovin®

The Spanish product information for Lacovin provides a useful example of why users should follow the actual leaflet. It describes topical dosing, the need for continued treatment and the fact that visible improvement is not immediate. Minoxidil treatment is generally measured in months, not days.

Regaxidil®

Regaxidil is also a useful example when explaining excipients. Two minoxidil products at the same nominal concentration can have different vehicles, and those vehicles can affect drying time, residue and scalp tolerance. Someone searching “Regaxidil alternative” may therefore be looking for a different user experience rather than a different active ingredient.

A balanced “Regaxidil vs FOLIGAIN” section should compare strength, solution versus foam availability, ingredients, pack size and country-specific instructions, while avoiding unsupported claims that one product produces more regrowth simply because of branding.

Loxon®

Loxon® is available in different strengths, so consumers comparing Loxon with FOLIGAIN® should first confirm the concentration, dosage form, ingredients and directions of the exact products being considered.

Minoxidil ABECE®, Apofri®, NET® and Orifarm®

Sweden is unusual because its current pharmacy landscape contains several generic-style branded minoxidil families. FASS currently lists Minoxidil ABECE 20 mg/ml and ABECE Forte 50 mg/ml, Minoxidil Apofri 20 mg/ml and Apofri Forte 50 mg/ml, Minoxidil NET 20 mg/ml and NET Forte 50 mg/ml, plus Minoxidil Orifarm 20 mg/ml, Orifarm Forte 50 mg/ml and a 50 mg/g Orifarm foam.

FASS also lists Rogaine 50 mg/g foam and Rogaine Forte 50 mg/ml solution, illustrating the range of minoxidil dosage forms available in Sweden.

For FOLIGAIN Sweden, the strongest angle is not to disparage these pharmacy brands. It is to help users understand what they are comparing and then present FOLIGAIN® Minoxidil as another relevant option in the local market.

Recrea® and Recrea Forte®

Recrea® and Recrea Forte® are useful Swedish historical search terms, but they should not be presented as if they were the current flagship minoxidil products on Swedish shelves. Current FASS minoxidil listings emphasize ABECE, Apofri, NET, Orifarm and Rogaine families instead.

Regaine® Forte in Denmark

Regaine Forte® is an important Danish minoxidil reference. Danish professional medicine information currently lists Regaine Forte as a 50 mg/ml cutaneous solution containing minoxidil and describes its use in androgenetic alopecia.

The Danish listing also identifies alcohol and propylene glycol among the excipients, which makes Regaine Forte a practical example when explaining why some consumers compare scalp feel and irritation potential in addition to active concentration.

Rogaine® in Finland and the Nordic region

The Nordic market illustrates one of the simplest but most important localization details: Rogaine® may be the relevant brand spelling instead of Regaine®. Finland and Sweden use the Rogaine name for current minoxidil products, and Rogaine is also familiar in Norway.

For European consumers, it is therefore useful to recognize both spellings: Regaine® is common in many countries, while Rogaine® is especially relevant in Finland and Sweden.

Neocapil®

Neocapil® is a Central European minoxidil search term, especially relevant in Czech and Slovak contexts. Because local marketing status and exact presentations can change, it is best handled with country-level verification before making strength-specific claims.

Belohair®

Belohair® is particularly relevant in Slovakia and nearby Central European markets. It should be treated as a regional brand rather than assumed to have the same status throughout Europe.

Consumers familiar with Belohair® can compare it with FOLIGAIN® by looking at minoxidil concentration, correct scalp application, dosage form, ingredients and treatment directions.

Minorga®

Minorga® is a regional minoxidil brand name whose current availability can vary by country. Check the exact local product and leaflet before comparing it with another minoxidil formulation.

Pilfud®

Pilfud® is an important Croatian minoxidil brand. Croatian official patient information describes PILFUD 50 mg/ml spray solution containing minoxidil and used for hereditary hair loss in adult men within the ages specified by the local leaflet.

FOLIGAIN® Minoxidil can be compared with Pilfud® by reviewing concentration, dosage form, ingredients and local product directions.

Loniten® and Oral Minoxidil

Loniten® must be treated differently from the topical brands above. Loniten is an oral minoxidil medicine historically used to treat severe or resistant hypertension. UK medicine information currently lists Loniten tablets in 2.5 mg, 5 mg and 10 mg strengths.

Interest in low-dose oral minoxidil for hair loss has grown, which is why many users now search “Loniten hair loss” or “oral minoxidil Europe.” But oral minoxidil is not simply topical minoxidil in tablet form from a consumer-risk perspective. Oral administration creates systemic exposure and can affect blood pressure, heart rate and fluid balance. Medical supervision is therefore a fundamentally different issue.

Kirkland Signature® Minoxidil

Kirkland Signature® Minoxidil is not a European pharmacy brand, but it generates substantial online search interest among European consumers because it is widely known from the North American market. It is commonly associated with 5% topical minoxidil products and is frequently sold cross-border through online marketplaces and resellers.

That creates a different set of questions from a local pharmacy product. Users need to consider seller authenticity, storage, labeling, import status and whether the product is legally marketed in their country. A low marketplace price does not answer those questions.

Member’s Mark® Minoxidil

Member’s Mark® Minoxidil is another North American retail-brand search term that occasionally appears in European comparison shopping. Like Kirkland, it should not be presented as a European nationally authorized pharmacy brand merely because European consumers can sometimes find it online.

Member’s Mark® is best considered an imported comparison product rather than a European pharmacy brand, and users should distinguish imported marketplace products from products sold specifically for a European market with local labeling.

Visit FOLIGAIN® Malta

In Malta, English-language minoxidil information is widely relevant. Consumers may encounter Regaine® and other topical minoxidil products while comparing 2%, 5%, foam and liquid formulations.

Malta

Visit FOLIGAIN® Latvia

Latvian consumers can compare topical minoxidil products according to concentration, format, excipients and local instructions. Cross-border brands may also appear, but local labeling remains important.

Latvia

Visit FOLIGAIN® Lithuania

In Lithuania, minoxidil is often best compared by active concentration, dosage form and ingredients rather than by relying on one dominant pan-European brand name.

Lithuania

Visit FOLIGAIN® Slovakia

Regional brand names such as Belohair®, Neocapil® and other minoxidil products may be familiar to Slovak consumers. Because availability can change, check the current product and local leaflet before making detailed comparisons.

Slovakia

Visit FOLIGAIN® Slovenia

Slovenian consumers may encounter Regaine® and other minoxidil products, but ingredient strength and product-specific directions should remain the main basis for comparison.

Slovenia

Visit FOLIGAIN® Croatia

Pilfud® is a notable Croatian minoxidil brand. Croatian patient information describes PILFUD 50 mg/ml topical spray solution containing minoxidil for hereditary hair loss in the users specified by the local leaflet.

Croatia

Visit FOLIGAIN® Greece

Alopexy® is an important minoxidil name in Greece, including a 50 mg/ml topical presentation. Greek consumers may also encounter other minoxidil products depending on pharmacy and market availability.

Greece

Visit FOLIGAIN® Romania

Romanian consumers may encounter Alopexy®, Regaine-related products and generic topical minoxidil. Concentration and local product directions remain more important than the brand name alone.

Romania

Visit FOLIGAIN® Hungary

Hungary’s medicine database lists Regaine 20 mg/ml external solution containing minoxidil. Other minoxidil products may also be encountered depending on current market availability.

Hungary

Visit FOLIGAIN® Poland

When comparing Loxon with FOLIGAIN®, check the exact strength, dosage form, ingredients and directions rather than assuming that the brand names describe different active ingredients.

Loxon® is one of the best-known minoxidil names in Poland. Polish consumers may encounter Loxon in different strengths and commonly refer to the active ingredient as minoksydyl.

Poland

Visit FOLIGAIN® Czechia

Czech consumers may encounter regional minoxidil names such as Neocapil® as well as ingredient-led topical minoxidil products. Current local availability and labeling should be checked because regional brands can change over time.

Czechia

Visit FOLIGAIN® Switzerland

Regardless of language, compare the exact active concentration, formulation and product directions rather than relying only on the brand name.

Switzerland is a multilingual market, so minoxidil may be researched in German, French or Italian. Consumers may therefore encounter European brands familiar from neighboring markets, including Regaine®, Alopexy® and Minoxidil Biorga®.

Switzerland

Visit FOLIGAIN® Finland

In Finland, the Rogaine® name is more relevant than the Regaine spelling used in many other European countries. Finnish consumers may encounter 5% minoxidil formulations in solution or foam formats depending on availability.

Finland

Visit FOLIGAIN® Denmark

As with other liquid minoxidil products, users who experience dryness or irritation may wish to check the excipients as well as the active concentration.

In Denmark, Regaine® Forte is an important minoxidil reference. Danish medicine information lists Regaine Forte as a 50 mg/ml topical solution containing minoxidil.

Denmark

Visit FOLIGAIN® Sweden

Older names such as Recrea® may still be encountered in searches or older discussions, but current product availability should always be checked before purchase.

Sweden has one of Europe’s broadest current sets of minoxidil brand names. FASS lists products under Minoxidil ABECE®, Minoxidil Apofri®, Minoxidil NET®, Minoxidil Orifarm® and Rogaine®, with 20 mg/ml and 50 mg/ml solutions represented and 5% foam also available in the market.

Sweden

Visit FOLIGAIN® Netherlands

Dutch consumers commonly compare topical minoxidil by concentration, dosage form and tolerance. The active ingredient remains the central point of comparison whether a product is sold under a recognized brand or a generic-style name.

Netherlands

Visit FOLIGAIN® Portugal

In Portugal, many consumers search primarily by the active ingredient rather than by a single dominant brand. Topical minoxidil 5%, liquid solutions and foam are common points of comparison. Imported brands such as Kirkland may also appear online, but imported products should be distinguished from products placed specifically on the Portuguese or wider European market.

Portugal

Visit FOLIGAIN® Spain

These products illustrate why the brand name alone does not tell the whole story. Two products may contain the same strength of minoxidil but differ in vehicle, excipients, applicator or directions.

Spain has several important minoxidil brands, including Lacovin®, Regaxidil® and Regaine®. Spanish medicine information documents Lacovin and Regaxidil in 20 mg/ml and 50 mg/ml topical presentations, corresponding to 2% and 5% minoxidil.

Spain

Visit FOLIGAIN® Germany

When comparing Regaine with FOLIGAIN®, consider the active concentration, format and ingredients as well as how easily the product fits into a consistent daily routine.

Regaine® is one of the most recognizable minoxidil names in Germany. German consumers may encounter liquid solutions and foam formulations designed for hereditary pattern hair loss.

Germany

Visit FOLIGAIN® Italy

The most useful comparison is still the formulation itself: 2% or 5%, solution or foam, ingredients, application schedule and suitability for the intended user. FOLIGAIN® Italy offers minoxidil products alongside the wider FOLIGAIN hair-thinning range.

Italy has a particularly broad minoxidil brand landscape. Names that Italian consumers may recognize include Carexidil®, Minoximen®, Minoxidil Biorga®, Regaine®, Trefostil®, Aloxidil®, Minovital® and Phalanx®. Availability can change over time, but these names remain useful reference points for understanding the Italian minoxidil market.

Italy

Visit FOLIGAIN® France

Anyone moving from one French minoxidil brand to another should compare the concentration, excipients and leaflet rather than assuming every product is used in exactly the same way.

French consumers may encounter several familiar minoxidil names, including Alopexy®, Minoxidil Bailleul® and Alostil®. France’s public medicine database lists both 2% and 5% topical minoxidil products, with approved users and directions depending on the exact presentation.

France

Visit FOLIGAIN® United Kingdom  |  Visit FOLIGAIN® Ireland

When comparing Regaine with FOLIGAIN®, check the active concentration, whether the product is a foam or solution, the application directions and the pack size. Do not assume that two 5% products have identical excipients or instructions simply because the concentration matches.

In the United Kingdom and Ireland, Regaine® is one of the best-known minoxidil brands. UK medicine information currently lists 5% foam and 5% solution for men, as well as women’s formulations. Irish consumers will also commonly encounter Regaine when researching topical minoxidil.

United Kingdom and Ireland

Minoxidil is available under different brand names and presentations across Europe. The concentration, dosage form and approved directions can vary from one country to another, so it is always important to check the specific product sold in your market. FOLIGAIN® also operates dedicated European stores so customers can view products and information intended for their country.

Minoxidil Across Europe: Country-by-Country Guide

How to Compare Minoxidil Brands Properly

1. Start with the concentration

Determine whether the product is 2% or 5% minoxidil. Do not assume that two differently branded packages contain different active ingredients simply because the names are different.

2. Compare solution and foam separately

Foam and liquid can have different excipients, dosing devices, drying times and application experiences. Compare like with like.

3. Read the excipient list

Propylene glycol, ethanol and other vehicle ingredients can matter to users with a sensitive or dry scalp.

4. Follow the national product directions

A product marketed in one country may not have identical directions to a similarly named product in another. Always follow the local leaflet for the product actually purchased.

5. Compare the amount of product per month

A lower bottle price does not necessarily mean a lower monthly treatment cost. Compare package quantity and the expected usage under the labeled dosing schedule.

6. Consider continuity

Because results generally require continued treatment, a product that fits comfortably into the user’s daily routine may be more practical than one they frequently skip.

7. Consider the source

For medicines, purchasing channel matters. Imported marketplace products can raise additional questions about authenticity, storage, labeling and local regulatory status.

FOLIGAIN® Minoxidil in Europe

FOLIGAIN® Europe serves consumers through a network of European storefronts and offers a broader hair-thinning portfolio than a single one-format minoxidil product. Depending on market availability, the range can include Minoxidil 5% for men, Minoxidil 2% for women, 5% foam, lower-alcohol formulations and advanced products combining Minoxidil 5% + TRIOXIDIL® 5%, alongside TRIOXIDIL®, 2dDR and TRICHOGEN® cosmetic products.

  • Does FOLIGAIN® offer the same 5% minoxidil concentration as a local 5% pharmacy product?
  • Is a foam available as well as a solution?
  • What is the difference between FOLIGAIN® Minoxidil and TRIOXIDIL®?
  • Does the chosen formulation contain alcohol or propylene glycol?
  • How much product is included and how long is the pack designed to last?
  • Which FOLIGAIN® product is intended for men or women in that market?

European FOLIGAIN storefronts

Frequently Asked Questions About Minoxidil in Europe

Is Regaine the same as minoxidil?

Regaine is a brand name used for certain topical minoxidil products. Minoxidil is the active ingredient.

Is Rogaine the same as Regaine?

They are closely related brand names used in different markets. Nordic countries such as Sweden and Finland commonly use the Rogaine name, while the UK and many other European markets use Regaine.

Is Alopexy minoxidil?

Yes. Alopexy is a brand name for topical minoxidil products. The exact strength and approved users depend on the presentation and country.

Is Minoxidil Bailleul the same as generic minoxidil?

Minoxidil Bailleul is a branded finished medicine containing minoxidil. A finished product also includes specific excipients, packaging and authorized directions.

What is the difference between Carexidil and FOLIGAIN?

Both names can refer to finished products containing minoxidil, but the exact concentration, vehicle, format, pack size and labeling should be compared product by product.

Is Loxon minoxidil?

Loxon is a major Polish brand associated with topical minoxidil. Polish users commonly search Loxon alongside the local spelling minoksydyl.

What is the best minoxidil brand in Europe?

There is no single brand that is automatically best for every user. Strength, formulation, excipients, labeled indication, tolerability, cost and consistency all matter.

Is 5% minoxidil better than 2%?

Five percent is a higher concentration, but it is not automatically appropriate for every user. Follow the label for the specific product and country.

Does minoxidil work on the hairline?

Response can vary by area and by how much viable miniaturized hair remains. Product-specific labeling and individual circumstances matter.

How long before minoxidil works?

Minoxidil is generally evaluated over months, not days. Several months of consistent use may be necessary before visible response can be assessed.

What happens if I stop minoxidil?

Benefits generally depend on continued use. Hair maintained or supported by treatment can gradually return toward the course it would have followed without treatment.

Can minoxidil cause shedding?

Temporary increased shedding can occur in some users after treatment begins. Persistent, severe or unusual shedding should be assessed.

Is minoxidil foam stronger than solution?

Not necessarily. Strength depends on the concentration. A 5% foam and 5% solution both contain 5% minoxidil but differ in vehicle and application.

Is oral minoxidil the same as topical minoxidil?

No. Oral minoxidil creates systemic exposure and has a different medical risk profile. It should not be treated as interchangeable with topical scalp products.

What is Loniten?

Loniten is an oral minoxidil medicine historically used as an antihypertensive. It is not a topical hair-loss brand.

Is Kirkland minoxidil a European pharmacy brand?

No. Kirkland Signature is primarily a North American retail brand and is usually encountered in Europe through import or online resale channels.

What is TRIOXIDIL®?

TRIOXIDIL® is a proprietary FOLIGAIN® cosmetic complex. It is not another name for minoxidil.

Can FOLIGAIN® be used instead of Regaine?

If comparing products that contain minoxidil, check the exact strength, dosage form, ingredients and local directions. Do not assume two products are identical simply because both contain minoxidil.

Official Sources and Further Reading

Because brand availability and labeling can change, this guide prioritizes current national medicine information where available.

Important Information

This article is provided for general educational and informational purposes and does not replace advice from a physician, dermatologist, pharmacist or other qualified healthcare professional. Minoxidil is a pharmaceutical active ingredient. Always follow the labeling and patient information supplied with the specific product sold in your country.

Brand availability, package sizes, strengths and approved indications can change over time and can differ between European countries. A brand mentioned in this directory should not be assumed to be currently marketed in every country. Sudden, severe, patchy or medically unexplained hair loss should be assessed appropriately before self-treatment.

Back to top